A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).

被引：7
|
作者：
Thomas, Reena Parada
Nagpal, Seema
Iv, Michael
Soltys, Scott G.
Corbin, Zachary
Xu, Linda Wei
Recht, Cathy Kahn
Bertrand, Sophie
Jain, Vani
Acevedo, Brenda
Brown, Martin
Recht, Lawrence David
机构：
[1] Stanford Univ Hosp, Stanford, CA 94305 USA
[2] Stanford Canc Ctr, Stanford, CA USA
[3] Stanford Canc Inst, Stanford, CA USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[6] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.2068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2068
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The survival impact of the time between surgery and chemo-radiotherapy in Glioblastoma patients
    Kaidar-Person, O.
    Zur, I.
    Tzuk-Shina, T.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S381 - S381
  • [42] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Kuo-Chen Wei
    Peng-Wei Hsu
    Hong-Chieh Tsai
    Ya-Jui Lin
    Ko-Ting Chen
    Cheng-Hong Toh
    Hui-Lin Huang
    Shih-Ming Jung
    Chen-Kan Tseng
    Yu-Xiong Ke
    Scientific Reports, 11
  • [43] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Wei, Kuo-Chen
    Hsu, Peng-Wei
    Tsai, Hong-Chieh
    Lin, Ya-Jui
    Chen, Ko-Ting
    Toh, Cheng-Hong
    Huang, Hui-Lin
    Jung, Shih-Ming
    Tseng, Chen-Kan
    Ke, Yu-Xiong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Fyn, AN ONCOGENE THAT REDUCES GLIOBLASTOMA SURVIVAL YET SENSITIZES TO CHEMO-RADIOTHERAPY
    Comba, Andrea
    Kadiyala, Padma
    Argento, Anna E.
    Patel, Priti
    Nunez, Felipe J.
    Saxena, Meghna
    Castro, Maria G.
    Lowenstein, Pedro R.
    NEURO-ONCOLOGY, 2017, 19 : 58 - 58
  • [45] Impact of Angiopoietin-2 on glioblastoma response to combined chemo-radiotherapy
    Helaine, C.
    Ferre, A. E.
    Leblond, M. M.
    Peres, E. A.
    Bernaudin, M.
    Valable, S.
    Petit, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma
    Setua, Sonali
    Ouberai, Myriam
    Piccirillo, Sara G.
    Watts, Colin
    Welland, Mark
    NANOSCALE, 2014, 6 (18) : 10865 - 10873
  • [47] The treatment of adults with medulloblastoma: a chemo-radiotherapy study
    Silvani, A
    Eoli, M
    Fariselli, L
    Salmaggi, A
    Botturi, A
    Broggi, G
    Boiardi, A
    JOURNAL OF NEUROLOGY, 2004, 251 : 170 - 170
  • [48] PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Glas, Martin
    Scheffler, Bjoern
    Lazaridis, Lazaros
    Herrlinger, Ulrich
    Pierscianek, Daniela
    Sure, Ulrich
    Proescholdt, Martin
    Hau, Peter
    Hense, Joerg
    Kleinschnitz, Christoph
    Grosu, Anca-Ligia
    Stuschke, Martin
    Kebir, Sied
    NEURO-ONCOLOGY, 2018, 20 : 22 - 22
  • [49] PRICOTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Glas, M.
    Scheffler, B.
    Lazaridis, L.
    Herrlinger, U.
    Pierscianek, D.
    Sure, U.
    Proescholdt, M.
    Hau, P.
    Hense, J.
    Kleinschnitz, C.
    Grosu, A.
    Stuschke, M.
    Kebir, S.
    NEURO-ONCOLOGY, 2018, 20 : 243 - 243
  • [50] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
12345